The Central government has allocated Rs 700 crore for establishing centres of excellence at National Institutes of Pharmaceutical Education & Research (NIPER) over the next five years, aiming to enhance the pharmaceutical and medical technology sectors. Rs 243 crore has been approved for 2024-25, focusing on research in medical device manufacturing, drug development, and more. Additionally, plans for a production-linked incentive scheme for GLP-1 drugs, addressing diabetes and obesity issues in India, are expected to roll out by 2026.
Comments are closed.